Harvest Investment Services’s Rhythm Pharmaceuticals RYTM Stock Holding History

Harvest Investment Services’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-48,468	Closed	-$4.22M	–	423
2026 Q1	$4.22M	Buy	48,468 +4,515	+10%	+$439K	0.77%	32
2025 Q4	$4.7M	Sell	43,953 -4,187	-9%	-$444K	0.89%	25
2025 Q3	$4.86M	Buy	48,140 +32,674	+211%	+$3.03M	0.98%	21
2025 Q2	$977K	Buy	+15,466	New	+$947K	0.22%	116
2022 Q4	–	Sell	-13,941	Closed	-$341K	–	136
2022 Q3	$341K	Buy	+13,941	New	+$259K	0.42%	75

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harvest Investment Services's RYTM Position: Q2 2026 in Review

Harvest Investment Services sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2026, closing a stake of 48,468 shares — an estimated $4.22M sold.

Harvest Investment Services first reported a position in RYTM in Q3 2022 and held it in 5 quarters. The position peaked at $4.86M in Q3 2025. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Harvest Investment Services reported no remaining Rhythm Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Harvest Investment Services sold 48,468 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $4.22M.
Harvest Investment Services first reported a position in Rhythm Pharmaceuticals in Q3 2022 and held it in 5 quarters.
Harvest Investment Services's Rhythm Pharmaceuticals position peaked at $4.86M in Q3 2025.
304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Harvest Investment Services's 13F filing for Q2 2026, filed 14 Aug 2026.